Dr. Sami Kamjoo, MD

Dr. Kamjoo practices at Kaiser Permanente South Bay Medical Center in Harbor City, California, part of Kaiser Permanente.

Dr. Kamjoo's NPI, 1528257060, was assigned on October 22, 2007. Dr. Kamjoo graduated from UC Irvine School of Medicine in 2006. Dr. Kamjoo holds California license A102003.

Dr. Kamjoo's primary practice is Kaiser Permanente South Bay Medical Center, at 25825 South Vermont Avenue, Harbor City, CA 90710 in Los Angeles County. The practice phone is (310) 325-5111.

Dr. Kamjoo's primary practice is Kaiser Permanente South Bay Medical Center in Harbor City, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Kamjoo to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kamjoo practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Kamjoo's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Kamjoo is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Kamjoo is licensed in California.

Dmand AI lists age-related macular degeneration, laser destruction of retinal or choroid lesions and surgical retina and vitreous procedures among the conditions Dr. Kamjoo treats.

CMS data shows 19 Medicare services from Dr. Kamjoo across 1 procedure code in 2024, all of them office visits, for 28 Medicare patients. Medicare paid $1,320 for them. Every service was in an office.

CMS counts 28 Medicare patients who saw Dr. Kamjoo in 2024. The largest group is 65 to 74, with 11 patients. 71% of them have high blood pressure, and 71% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kamjoo's median patient age at 67, with 50% women.

In 2024, Dr. Kamjoo wrote 751 Medicare Part D claims for 222 patients. 80% of them were for generic drugs. CMS names the drug for 677 of them, across 12 drugs with 11 or more claims each, at $21,861 in total drug cost. In 2023, CMS named 623 claims across 11 drugs.

Dr. Kamjoo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Kamjoo. The most frequent topics are Pigment Epithelium of Eye, Cell Line and Cell Survival. Dr. Kamjoo has published most often in Invest Ophthalmol Vis Sci. Dr. Kamjoo's most frequent co-authors are Baruch D. Kuppermann, MD and Babak Fardin, MD.

CMS Open Payments shows 3 general payments to Dr. Kamjoo from 3 drug and device companies from 2020 to 2023. Food and beverage make up the largest share, 77% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $122.

Dmand AI lists 1 award for Dr. Kamjoo, most recently CMS Stage 1 EHR in 2012.

Dr. Kamjoo graduated from UC Irvine School of Medicine in 2006.

Dr. Kamjoo is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Kaiser Permanente and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.